What a great opportunity to start establishing a position at this price with some decent catalysts to come in the next few months
- Forums
- ASX - By Stock
- ATX
- Ann: Type D Meeting Outcome With US Food And Drug Administration
ATX
amplia therapeutics limited
Add to My Watchlist
2.86%
!
17.0¢

Ann: Type D Meeting Outcome With US Food And Drug Administration, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $65.95M |
Open | High | Low | Value | Volume |
16.5¢ | 17.5¢ | 16.5¢ | $128.9K | 753.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 143339 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 70000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 143339 | 0.165 |
8 | 336623 | 0.160 |
10 | 699287 | 0.155 |
18 | 530861 | 0.150 |
3 | 172965 | 0.145 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 70000 | 2 |
0.175 | 14230 | 2 |
0.180 | 616576 | 6 |
0.185 | 186291 | 8 |
0.190 | 650000 | 3 |
Last trade - 10.40am 26/06/2025 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online